Hetero USA Inc FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Mar 17, 2017
  • No warning letters matched by name
Inspections 2 0 OAI
Recalls 4 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Hetero USA Inc has 4 FDA recalls, 2 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Hetero USA Inc" is on file.

What these totals cover: FDA records filed under the name "Hetero USA Inc" and its spelling variant "Hetero Usa".

Latest recall
D-0530-2023 · Class II · Mar 14, 2023
Latest inspection
Mar 17, 2017 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls4Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections2Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Hetero USA Inc's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Hetero USA Inc: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300010
202200000
202100000
202000000
201900000
201800000
201710030

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Hetero USA Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Hetero USA Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

4 recall records from Jan 7, 2017 to Mar 14, 2023.

NumberClassProductDate
D-0530-2023Class IIPantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for…Mar 14, 2023
D-1095-2017Class IIEntecavir Tablets 0.5 mg, 30 tablets per container, Rx Only, Manufactured for: Camber…Jul 20, 2017
D-0897-2017Class IIIAcyclovir Tablets, USP, 800 mg, 100-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals…Apr 27, 2017
D-0623-2017Class IIIMontelukast sodium tablets, 10 mg, 30-count bottle, Rx Only, Manufactured for: Camber…Jan 7, 2017

Recent FDA inspections

2 inspections from Jul 20, 2011 to Mar 17, 2017.

DateSiteProductClassificationFEI
Mar 17, 2017Piscataway, NJDrugsVoluntary Action Indicated (VAI)3008903511
Jul 20, 2011Piscataway, NJDrugsVoluntary Action Indicated (VAI)3008903511
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3008903511Piscataway, NJ2Mar 17, 2017

Hetero USA Inc and the FDA: common questions

Has Hetero USA Inc received an FDA warning letter?

No FDA warning letter addressed to the name "Hetero USA Inc" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Hetero USA Inc received an FDA Form 483?

FDA has not published a Form 483 for "Hetero USA Inc" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Hetero USA Inc?

The most recent FDA inspection on file ended Mar 17, 2017 at Piscataway, NJ and was classified VAI. FDA has 2 inspections of Hetero USA Inc on file.

Has Hetero USA Inc had an FDA recall?

Yes. Hetero USA Inc has 4 FDA recalls on record. The most recent started Mar 14, 2023.

Need more than this page shows? Ask about Hetero USA Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.